BG Medicine Inc (BGMD)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

610N LINCOLN STREET WALTHAM, MA 02451

BG Medicine, Inc., a life sciences company, engages in the discovery, development, and commercialization of diagnostic tests based on biomarkers in the United States.

Data as of 2020-11-22
Market Cap246.824 Thousand Shares Outstanding11.374 Million Avg 30-day Volume8.083 Thousand
P/E Ratio0.0 Dividend Yield EPS-0.72
Price/Sales Price cash flow ratio Price free cash flow ratio
Book Value-0.17 Price to Tangible Book-0.12 Alpha0.01
Short Interest Ratio2.572 % Short Interest to Float7.2 R-squared9.0e-06
BETA-0.032609 52-week High/Low0.05 / 0.0071 Stddev0.468797
View SEC Filings from BGMD instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BGMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BGMD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SEAWELL HAYGOOD PATERSON SR

  • PRIVATE INVESTOR
1,298,965 2016-05-05 0

ADOURIAN ARAM S. SVP & CHIEF SCIENTIFIC OFFICER

  • Officer
35,770 2016-03-31 0

SOHMER PAUL R PRESIDENT & CEO

  • Officer
  • Director
53,161 2016-03-31 0

HALL STEPHEN P EVP & CHIEF FINANCIAL OFFICER

  • Officer
31,034 2016-03-31 0

LUBER JEFFREY R

  • Director
0 2016-02-04 0

AFEYAN NOUBAR

  • Director
  • 10% Owner
1,286,274 2015-12-09 0

PAPADOPOULOS STELIOS

  • Director
0 2015-11-18 0

WILCOX HARRY W

  • Director
0 2015-11-18 0

OCONNOR JAMES F O

  • Director
0 2015-11-18 0

AFEYAN NOUBAR

FLAGSHIP VENTURES MANAGEMENT, INC.

NEWCOGEN GROUP, INC.

APPLIED GENOMIC TECHNOLOGY CAPITAL FUND LP

AGTC PARTNERS, L.P.

  • Director
  • 10% Owner
1,328,234 2015-07-27 0

AFEYAN NOUBAR

FLAGSHIP VENTURES MANAGEMENT, INC.

NEWCOGEN GROUP, INC.

AGTC ADVISORS FUND LP

AGTC PARTNERS, L.P.

  • Director
  • 10% Owner
1,332,712 2015-07-27 0

FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND 2007, L.P.

  • 10% Owner
441,071 2015-07-14 0

AFEYAN NOUBAR

KANIA EDWIN M JR

FLAGSHIP VENTURES MANAGEMENT, INC.

NEWCOGEN GROUP, INC.

AGTC PARTNERS, L.P.

AGTC ADVISORS FUND LP

APPLIED GENOMIC TECHNOLOGY CAPITAL FUND LP

FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND 2007, L.P.

  • Director
  • 10% Owner
0 2015-07-14 0

KANIA EDWIN M JR

  • 10% Owner
5,805,282 2014-12-09 0

AFEYAN NOUBAR

ST NEWCOGEN LLC

KANIA EDWIN M JR

FLAGSHIP VENTURES MANAGEMENT, INC.

NEWCOGEN GROUP, INC.

  • Director
  • 10% Owner
8,009,400 2014-12-03 0

AFEYAN NOUBAR

NEWCOGEN LONG REIGN HOLDING LLC

KANIA EDWIN M JR

FLAGSHIP VENTURES MANAGEMENT, INC.

NEWCOGEN GROUP, INC.

  • Director
  • 10% Owner
7,917,106 2014-12-03 0

AFEYAN NOUBAR

NEWCOGEN EQUITY INVESTORS LLC

KANIA EDWIN M JR

FLAGSHIP VENTURES MANAGEMENT, INC.

NEWCOGEN GROUP, INC.

  • Director
  • 10% Owner
7,265,546 2014-12-03 0

AFEYAN NOUBAR

NEWCOGEN GROUP LLC

KANIA EDWIN M JR

FLAGSHIP VENTURES MANAGEMENT, INC.

NEWCOGEN GROUP, INC.

  • Director
  • 10% Owner
5,016,493 2014-12-03 0

BANCEL STEPHANE

  • Director
0 2014-06-03 0

POSNER BRIAN S

  • Director
0 2014-06-03 0

BAINS HARRISON M JR

  • Director
0 2014-06-03 0

HARRIS TIMOTHY J.R.

  • Director
0 2014-06-03 0

RADER ANASTASIA SVP, EXECUTIVE OPERATIONS & HR

  • Officer
0 2014-02-04 0

AFEYAN NOUBAR

KANIA EDWIN M JR

FLAGSHIP VENTURES MANAGEMENT, INC.

NEWCOGEN GROUP, INC.

NEWCOGEN GROUP LLC

NEWCOGEN EQUITY INVESTORS LLC

AGTC PARTNERS, L.P.

AGTC ADVISORS FUND LP

APPLIED GENOMIC TECHNOLOGY CAPITAL FUND LP

  • Director
  • 10% Owner
8,186,182 2013-01-30 0

ABDALIAN CHARLES H JR EVP & CHIEF FINANCIAL OFFICER

  • Officer
0 2012-12-10 0

AFEYAN NOUBAR

NEWCOGEN ELAN LLC

KANIA EDWIN M JR

FLAGSHIP VENTURES MANAGEMENT, INC.

NEWCOGEN GROUP, INC.

  • Director
  • 10% Owner
6,186,182 2012-08-20 0

DENSEL WILLIAM GENERAL MANAGER, CARDIOSCORE

  • Officer
0 2012-08-08 0

MUNTENDAM PIETER EVP, CHIEF MEDICAL OFFICER

  • Officer
78,483 2012-06-07 0

BOUVIER ERIC PRESIDENT, CEO

  • Officer
  • Director
10,000 2012-05-23 0

AFEYAN NOUBAR

NEWCOGEN PE LLC

KANIA EDWIN M JR

FLAGSHIP VENTURES MANAGEMENT, INC.

NEWCOGEN GROUP, INC.

  • Director
  • 10% Owner
6,462,782 2012-05-21 0

VAN DER MEER PIETER

GILDE EUROPE FOOD & AGRIBUSINESS FUND B.V.

GILDE AGRIBUSINESS MANAGEMENT B.V.

GILDE HEALTHCARE HOLDING B.V.

DE GRAAF EDWIN

PERRET MARC OLIVIER

GILDE EUROPE FOOD & AGRIBUSINESS PARTNERS II C.V.

  • 10% Owner
No longer subject to file 2012-04-17 0

GORDON NEAL SVP, BIOMARKER DISCOVERY

  • Officer
0 2012-02-22 0

ROGERS MICHAEL W EVP, CFO AND TREASURER

  • Officer
0 2012-02-22 0

MILLER STEPHEN R. CHIEF COMMERCIAL OFFICER

  • Officer
0 2012-02-22 0

SHEPHERD WAYNE K. VP, SALES AND MARKETING

  • Officer
0 2011-03-02 0

AFEYAN NOUBAR

KANIA EDWIN M JR

FLAGSHIP VENTURES MANAGEMENT, INC.

NEWCOGEN GROUP, INC.

NEWCOGEN GROUP LLC

NEWCOGEN EQUITY INVESTORS LLC

NEWCOGEN ELAN LLC

NEWCOGEN LONG REIGN HOLDING LLC

NEWCOGEN PE LLC

ST NEWCOGEN LLC

  • Director
  • 10% Owner
6,760,843 2011-02-09 0

AGTC PARTNERS, L.P.

AGTC ADVISORS FUND LP

APPLIED GENOMIC TECHNOLOGY CAPITAL FUND LP

  • 10% Owner
2,491,460 2011-02-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments